Literature DB >> 33305889

The relationship between excessive dietary fructose consumption and paediatric fatty liver disease.

Johanna K DiStefano1, Gabriel Q Shaibi2.   

Abstract

The global prevalence of non-alcoholic fatty liver disease (NAFLD) in children and adolescents is escalating and currently represents the most common chronic liver disease in the paediatric population. NAFLD is associated with high daily caloric intake and sedentary behaviour, with excessive consumption of added sugar emerging as an important contributor to NAFLD risk in children. This is a particularly important factor for adolescents with obesity, who are the heaviest consumers of added sugar. Table sugar, or sucrose, is a disaccharide comprised of fructose and glucose, yet only fructose has been strongly linked to NAFLD pathogenesis largely due to the unique characteristics of its metabolism and detrimental effects on key metabolic pathways. To date, the relationship between excessive fructose intake and risk of NAFLD in children and adolescents remains incompletely understood, and it is not yet known whether fructose actually causes NAFLD or instead exacerbates hepatic fat accumulation and possible hepatocellular injury only within the context of cardiometabolic factors. The purpose of this review is to summarize recent studies linking fructose consumption with NAFLD in the paediatric population and integrate results from interventional studies of fructose restriction in children and adolescents on NAFLD and related metabolic markers. Given the overall positive impact of lifestyle modifications in the management of paediatric NAFLD, reduction of added sugar consumption may represent an important, early opportunity to mitigate or prevent NAFLD in high-risk children and adolescents.
© 2020 World Obesity Federation.

Entities:  

Keywords:  fructose; hepatic steatosis; liver fibrosis; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; uric acid

Mesh:

Substances:

Year:  2020        PMID: 33305889      PMCID: PMC8195317          DOI: 10.1111/ijpo.12759

Source DB:  PubMed          Journal:  Pediatr Obes        ISSN: 2047-6302            Impact factor:   3.910


  67 in total

1.  Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.

Authors:  Stavra A Xanthakos; Joel E Lavine; Katherine P Yates; Jeffrey B Schwimmer; Jean P Molleston; Philip Rosenthal; Karen F Murray; Miriam B Vos; Ajay K Jain; Ann O Scheimann; Tamir Miloh; Mark Fishbein; Cynthia A Behling; Elizabeth M Brunt; Arun J Sanyal; James Tonascia
Journal:  Gastroenterology       Date:  2020-07-23       Impact factor: 22.682

2.  Rapid progression of NASH in childhood.

Authors:  Rohit Kohli; Todd Boyd; Kathleen Lake; Kim Dietrich; Lynda Nicholas; William F Balistreri; Dawn Ebach; Harohadli Shashidhar; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-04       Impact factor: 2.839

3.  Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response.

Authors:  S E Perez-Pozo; J Schold; T Nakagawa; L G Sánchez-Lozada; R J Johnson; J López Lillo
Journal:  Int J Obes (Lond)       Date:  2009-12-22       Impact factor: 5.095

4.  Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study.

Authors:  Christine Carter-Kent; Lisa M Yerian; Elizabeth M Brunt; Paul Angulo; Rohit Kohli; Simon C Ling; Stavra A Xanthakos; Peter F Whitington; Phunchai Charatcharoenwitthaya; Jason Yap; Rocio Lopez; Arthur J McCullough; Ariel E Feldstein
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

5.  Role of the kidney in the metabolism of fructose in 60-hour fasted humans.

Authors:  O Björkman; P Felig
Journal:  Diabetes       Date:  1982-06       Impact factor: 9.461

Review 6.  Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges.

Authors:  Dana Goldner; Joel E Lavine
Journal:  Gastroenterology       Date:  2020-03-20       Impact factor: 22.682

7.  Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study.

Authors:  Maggie A Stanislawski; Jessica Shaw; Elizabeth Litkowski; Ethan M Lange; Wei Perng; Dana Dabelea; Leslie A Lange
Journal:  J Pediatr       Date:  2020-03-04       Impact factor: 4.406

8.  The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids.

Authors:  Cholsoon Jang; Sheng Hui; Wenyun Lu; Alexis J Cowan; Raphael J Morscher; Gina Lee; Wei Liu; Gregory J Tesz; Morris J Birnbaum; Joshua D Rabinowitz
Journal:  Cell Metab       Date:  2018-02-06       Impact factor: 27.287

9.  Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity.

Authors:  Jean-Marc Schwarz; Susan M Noworolski; Ayca Erkin-Cakmak; Natalie J Korn; Michael J Wen; Viva W Tai; Grace M Jones; Sergiu P Palii; Moises Velasco-Alin; Karen Pan; Bruce W Patterson; Alejandro Gugliucci; Robert H Lustig; Kathleen Mulligan
Journal:  Gastroenterology       Date:  2017-06-01       Impact factor: 22.682

10.  Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans.

Authors:  Chad L Cox; Kimber L Stanhope; Jean Marc Schwarz; James L Graham; Bonnie Hatcher; Steven C Griffen; Andrew A Bremer; Lars Berglund; John P McGahan; Nancy L Keim; Peter J Havel
Journal:  Nutr Metab (Lond)       Date:  2012-07-24       Impact factor: 4.169

View more
  6 in total

1.  Establishing 24-Hour Urinary Sucrose Plus Fructose as a Predictive Biomarker for Total Sugars Intake.

Authors:  Laurence S Freedman; Victor Kipnis; Douglas Midthune; John Commins; Brian Barrett; Virag Sagi-Kiss; Susana A Palma-Duran; Carol S Johnston; Diane M O'Brien; Natasha Tasevska
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-06-01       Impact factor: 4.090

Review 2.  Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment.

Authors:  Bo Zhu; Siu-Lung Chan; Jack Li; Kathryn Li; Hao Wu; Kui Cui; Hong Chen
Journal:  Front Cardiovasc Med       Date:  2021-09-07

Review 3.  Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19.

Authors:  Ioannis Ilias; Spyridon Goulas; Lina Zabuliene
Journal:  World J Clin Cases       Date:  2021-04-26       Impact factor: 1.337

Review 4.  Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence.

Authors:  Shanmugam Murugaiha Jeyakumar; Ayyalasomayajula Vajreswari
Journal:  World J Hepatol       Date:  2022-01-27

5.  Gut Microbiota Induced by Pterostilbene and Resveratrol in High-Fat-High-Fructose Fed Rats: Putative Role in Steatohepatitis Onset.

Authors:  Iñaki Milton-Laskibar; Laura Judith Marcos-Zambrano; Saioa Gómez-Zorita; Alfredo Fernández-Quintela; Enrique Carrillo de Santa Pau; J Alfredo Martínez; María P Portillo
Journal:  Nutrients       Date:  2021-05-20       Impact factor: 5.717

Review 6.  NAFLD in normal weight individuals.

Authors:  Johanna K DiStefano; Glenn S Gerhard
Journal:  Diabetol Metab Syndr       Date:  2022-03-24       Impact factor: 5.395

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.